pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

917 catalysts · 3,288 8k filing · 1,642 grant · 1,000 device adverse event · 755 approval · 597 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: recall×from 2026-02-10×clear all
type
  • 8k filing3,288
  • grant1,642
  • device adverse event1,000
  • approval755
  • device 510k597
  • earnings584
device pma
455
  • device recall178
  • phase 2 completion172
  • recall162
  • therapy area

    no tagged catalysts yet

    Week of Feb 9, 2026

    50
    ›Feb 10, 2026approval185d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Feb 10, 2026approval185d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Feb 10, 2026approval185d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval185d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUDROCORTISONE ACETATE — FDA approvalNovitium Pharma LLC

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoTRETINOIN — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: ENCUBE. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoSULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval185d agoGLYCOPYRROLATE — FDA approvalGLYCOPYRROLATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Feb 10, 2026approval185d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: HIKMA. Form: TABLET. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Feb 11, 2026approval184d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval184d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

    Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 11, 2026approval184d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Feb 11, 2026approval184d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Feb 11, 2026approval184d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval184d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval184d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ›Feb 11, 2026approval184d agoBRIMONIDINE TARTRATE — FDA approvalBausch & Lomb Corp

    Sponsor: DR REDDYS LABS SA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 11, 2026recall184d agoUnichem Pharmaceuticals USA Inc. recall (Cls II)Universe Pharmaceuticals INC

    Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01 — Reason: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 11, 2026recall184d agoGreen Lumber Holdings, LLC recall (Cls I)Shenzhen Hanhui Pharmaceutical Technology Co Ltd

    Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660 — Reason: Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 11, 2026recall184d agoGranules Pharmaceuticals Inc. recall (Cls II)LB PHARMACEUTICALS INC

    Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01. — Reason: Presence of Foreign Tablets/Capsules — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 11, 2026recall184d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7 — Reason: Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 11, 2026recall184d agoHANDELNINE GLOBAL LLC recall (Cls I)

    Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 — Reason: CGMP Deviations: product found to contain lead. — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 12, 2026approval183d agoCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →CLEOCIN →fda approvals ↗
    ›Feb 12, 2026approval183d agoCLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalclindamycin hydrochloride

    Sponsor: PFIZER. Form: CAPSULE. Route: ORAL

    full page →clindamycin hydrochloride →fda approvals ↗
    ›Feb 12, 2026approval183d agoCLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →CLEOCIN →fda approvals ↗
    ›Feb 12, 2026approval183d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Feb 12, 2026approval183d agoENJUVIA (ESTROGENS, CONJUGATED SYNTHETIC B) — FDA approvalENJUVIA

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →ENJUVIA →fda approvals ↗
    ›Feb 12, 2026approval183d agoFLUOROMETHOLONE — FDA approvalDifGen Pharmaceuticals LLC

    Sponsor: DIFGEN PHARMS. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Feb 12, 2026approval183d agoLEQVIO (INCLISIRAN SODIUM) — FDA approvalinclisiran

    Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →inclisiran →fda approvals ↗
    ›Feb 12, 2026approval183d agoLEQVIO (INCLISIRAN SODIUM) — FDA approvalinclisiran

    Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →inclisiran →fda approvals ↗
    ›Feb 12, 2026approval183d agoPROMETRIUM (PROGESTERONE) — FDA approvalIBSA Institut Biochimique SA

    Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 12, 2026approval183d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: ALKEM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 12, 2026approval183d agoADQUEY (DIFAMILAST) — FDA approvaldifamilast

    Sponsor: ACROTECH BIOPHARMA. Form: OINTMENT. Route: TOPICAL

    full page →difamilast →fda approvals ↗
    ›Feb 12, 2026approval183d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 12, 2026approval183d agoENZEEVU (AFLIBERCEPT-ABZV) — FDA approvalaflibercept biosimilar

    Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

    full page →aflibercept biosimilar →fda approvals ↗
    ›Feb 12, 2026approval183d agoBIJUVA (ESTRADIOL) — FDA approval(estradiol + progesterone)

    Sponsor: MAYNE PHARMA. Form: CAPSULE. Route: ORAL

    full page →(estradiol + progesterone) →fda approvals ↗
    ›Feb 12, 2026approval183d agoESTRING (ESTRADIOL) — FDA approvalestradiol ER

    Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL

    full page →estradiol ER →fda approvals ↗
    ›Feb 12, 2026approval183d agoPEPCID AC (FAMOTIDINE) — FDA approvalKenvue Inc.

    Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 12, 2026approval183d agoAMMONIUM LACTATE — FDA approvalAMMONIUM LACTATE

    Sponsor: ZYDUS LIFESCIENCES. Form: CREAM. Route: TOPICAL

    full page →AMMONIUM LACTATE →fda approvals ↗
    ›Feb 12, 2026approval183d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 12, 2026approval183d agoDIVIGEL (ESTRADIOL) — FDA approvalVertical Pharmaceuticals LLC

    Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Feb 12, 2026approval183d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    ›Feb 12, 2026approval183d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Feb 12, 2026approval183d agoCELECOXIB — FDA approvalScilex Holding Co

    Sponsor: QINGDAO BAHEAL PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 13, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ZYDUS LIFESCIENCES. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 13, 2026approval182d agoAVOPEF (ETOPOSIDE) — FDA approvaletoposide

    Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS

    full page →etoposide →fda approvals ↗
    ›Feb 13, 2026approval182d agoCEFAZOLIN SODIUM — FDA approvalSamson Medical Technologies LLC

    Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 13, 2026approval182d agoWAKIX (PITOLISANT HYDROCHLORIDE) — FDA approvalpitolisant hydrochloride

    Sponsor: HARMONY. Form: TABLET. Route: ORAL

    full page →pitolisant hydrochloride →fda approvals ↗
    ← prev
    page 1 of 19
    next →
    $UPC2.5000-3.10%
    $PFE26.80+1.86%
    $BLCO16.98+1.31%
    $PFE26.80+1.86%
    $PFE26.80+1.86%
    $NVS151.72-0.39%
    $NVS151.72-0.39%
    $ASPU0.2893-0.26%
    $KVUE19.20+1.16%
    $PFE26.80+1.86%
    $PFE26.80+1.86%
    $PFE26.80+1.86%
    $ASPU0.2893-0.26%
    $SCLX8.8000+25.00%
    $HRMY38.50-3.19%
    $LBRX44.27-2.45%
    $TEVA36.52-0.60%